Viamet withdraws IPO

Viamet Pharmaceuticals Inc. (Durham, N.C.) withdrew its proposed IPO on NASDAQ. The company did not provide a reason in its SEC filing and did not respond to inquiries. In July, the infectious disease play filed to raise up to $75 million in an offering underwritten by Piper Jaffray; Wells Fargo and Stifel. ...